Eastern Hepatobiliary Surgery Hospital
Clinical trials sponsored by Eastern Hepatobiliary Surgery Hospital, explained in plain language.
-
New combo therapy aims to shrink unresectable bile duct tumors
Disease control Recruiting nowThis study tests a treatment for people with advanced bile duct cancer (ICC) that cannot be removed by surgery. The treatment combines chemotherapy given directly into the liver (HAIC) with immunotherapy drugs. The goal is to see if this combination can shrink tumors enough to al…
Phase: PHASE2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could changing the order of two cancer drugs boost their power?
Disease control Recruiting nowThis study tests whether giving the drug bevacizumab alone first, then adding atezolizumab later, works better than giving both drugs together from the start. It involves 20 adults with advanced liver cancer who also have fatty liver disease. The goal is to see if the sequential …
Phase: PHASE2, PHASE3 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Supercharged immune cells take on advanced liver cancer
Disease control Recruiting nowThis study tests a new immune cell therapy called Super Hi-TCR-T cells in 30 people with advanced liver cancer that has not responded to standard treatments. The cells are designed to attack multiple targets on cancer cells. Participants receive the cells after a short chemothera…
Phase: PHASE1, PHASE2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:00 UTC